BC
IONS icon

Brinker Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Brinker Capital’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-9,224
Closed -$384K – 997
2018
Q2 		$384K Buy
9,224
+579
+7% +$25.7K 0.01% 792
2018
Q1 		$381K Buy
8,645
+449
+5% +$22.8K 0.01% 801
2017
Q4 		$412K Sell
8,196
-277
-3% -$15.2K 0.02% 753
2017
Q3 		$430K Buy
+8,473
New +$444K 0.02% 712
2017
Q2 		– Sell
-8,242
Closed -$331K – 767
2017
Q1 		$331K Buy
8,242
+592
+8% +$26.6K 0.02% 750
2016
Q4 		$366K Buy
+7,650
New +$303K 0.02% 523

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return